IL7 (Interleukin 7) CTS™ Recombinant Human Protein
Product Image
Gibco™

IL7 (Interleukin 7) CTS™ Recombinant Human Protein

Recombinant IL7 is a bioactive protein intended for use in cell culture applications. IL7 stimulates the proliferation of pre-B andRead more
Have Questions?
Catalog number CTP0071
Price (CNY)
45,379.00
100 µg
Add to cart
Price (CNY)
45,379.00
100 µg
Add to cart
Recombinant IL7 is a bioactive protein intended for use in cell culture applications. IL7 stimulates the proliferation of pre-B and pro-B cells. IL7 also supports the maturation of megakaryocytes. ED50 range = 0.2 to 1 ng⁄mL (Specific Activity: 5.0 x 10^6 to 1.0 x 10^6 units⁄mg), determined by the dose dependent proliferation of human PBMCs. Optimal concentration for individual application should be determined by a dose response assay.
For Research Use Only. Not for use in diagnostic procedures.
Specifications
Activity0.855 ng/ml
BioassayProliferation of human PBMCs
ClassificationCarrier-Free
Endotoxin Level< 0.1 ng/μg
Expression SystemE. coli
Gene AliasIL-7 (Interleukin 7)
Molecular Weight (g/mol)17.5 kDa
Product LineGibco
Protein FamilyCytokines & Receptors
Protein FormFull Length, Recombinant, Ligand
Protein SubtypeInterleukins
Purification MethodGel-Purified
Purity or Quality Grade95 %
Quantity100 μg
ReactivityHuman
Research CategoryClinical Research, Signal Transduction, Stem Cell Research, Drug Development, Immunology, Oncology
Shipping ConditionWet Ice
For Use With (Application)Cell Culture
RecombinantRecombinant
SpeciesHuman
Unit Size100 µg
Contents & Storage
Lyophilized protein can be stored at 2-8°C dessicated. Once reconstituted, store in aliquots at ≤20°C. Avoid multiple freeze⁄thaw cycles.

Frequently asked questions (FAQs)

It looks like the recombinant protein vial I received from you is empty. Is this normal?

Gibco recombinant proteins are frequently formulated without carrier proteins or additives (e.g., BSA, HSA, sucrose, etc.) and no Gibco PeproTech recombinant protein contains a carrier protein. As a result, during lyophilization, the protein product may be deposited on the vial as a thin, and sometimes invisible, film instead of a pellet. The size of the pellet, if any, is not directly related to the quantity of the recombinant protein in the vial. Our quality control procedures assure that each vial contains the correct amount of product.

To ensure complete recovery of protein product, before opening a vial of lyophilized recombinant protein, we recommend centrifuging it in a microcentrifuge for 20-30 seconds to drive any protein that may be lodged in the cap or on the side to the bottom of the vial. After reconstitution, you can confirm the presence of product protein by running a small amount on SDS-PAGE. In general, a protein band with expected size should be visible with as little as 10 ng of protein loaded on an acrylamide gel.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

Why does my recombinant protein not show activity in my own experiment?

Assay time is critical. Each assay needs to beoptimized and performed at the peak response time. Different cells may respond differently to a growth factor or cytokine. We suggest repeating our QC assay using same indicator cells as suggested in the manual to see if you can obtain a similar response. In addition, serum may be masking the response. Serum starvation might be needed for certain types of assays.

How should I store the reconstituted recombinant proteins?

Protein solutions are generally not very stable when frozen at low concentration. Upon freeze and thaw, some proteins in the solution may stick to the wall of the container, which results in significant reduction of protein concentration if the starting concentration was low. Therefore, carrier proteins are used to reduce such loss. The most commonly used carrier proteins include bovine serum albumin (BSA), human serum albumin (HSA), or fetal bovine serum (FBS). These carrier proteins are generally used at 0.1% concentration. As a rule of thumb, if the concentration of the recombinant protein is less than 0.5 mg/mL, it is a good idea to add some carrier protein

How do I store my lyophilized recombinant protein?

Lyophilized proteins can typically be stored at 2 to 8 degrees C for several weeks, or stored dessicated at -20 degrees C for long-term storage.

Citations & References (6)

Citations & References
Abstract
Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella Type III secretion system.
Authors:Kotton CN, Lankowski AJ, Scott N, Sisul D, Chen LM, Raschke K, Borders G, Boaz M, Spentzou A, Galán JE, Hohmann EL
Journal:Vaccine
PubMed ID:16824652
CKS257 (Salmonella typhimurium SL1344 DeltaphoP/phoQDelta aroA Deltaasd DeltastrA/strB pSB2131) is a live oral vaccine vector expressing HIV Gag.
Identification of an immunogenic CTL epitope of HIFPH3 for immunotherapy of renal cell carcinoma.
Authors:Sato E, Torigoe T, Hirohashi Y, Kitamura H, Tanaka T, Honma I, Asanuma H, Harada K, Takasu H, Masumori N, Ito N, Hasegawa T, Tsukamoto T, Sato N
Journal:Clin Cancer Res
PubMed ID:18980986
CD8(+) CTLs have an essential role in immune response against tumor. Although tumor-associated antigens have been identified in renal cell carcinoma (RCC), few of these are commonly shared and investigated as therapeutic targets in the clinical medicine. In this report, we show that HIFPH3, a member of prolyl hydroxylases that ... More
IL-4 influences the differentiation and the susceptibility to activation-induced cell death of human naive CD8+ T cells.
Authors:Riou C, Dumont AR, Yassine-Diab B, Haddad EK, Sekaly RP
Journal:Int Immunol
PubMed ID:16611649
It is now well established that the cytokine environment influences the activation, differentiation, proliferation and death of T lymphocytes during the primary response to antigen. Using an in vitro model, we investigated the influence of IL-4, added at the onset of TCR stimulation, on phenotypic and functional markers of naive ... More
Identification of a hepatitis C virus-reactive T cell receptor that does not require CD8 for target cell recognition.
Authors:Callender GG, Rosen HR, Roszkowski JJ, Lyons GE, Li M, Moore T, Brasic N, McKee MD, Nishimura MI
Journal:Hepatology
PubMed ID:16628627
Hepatitis C virus (HCV) has been reported to elicit B and T cell immunity in infected patients. Despite the presence of antiviral immunity, many patients develop chronic infections leading to cirrhosis, hepatocellular carcinoma, and liver failure that can require transplantation. We have previously described the presence of HLA-A2-restricted, HCV NS3-reactive ... More
Expression of the IL-7 receptor alpha-chain is down regulated on the surface of CD4 T-cells by the HIV-1 Tat protein.
Authors:McLaughlin D, Faller E, Sugden S, MacPherson P
Journal:
PubMed ID:25333710
HIV infection elicits defects in CD4 T-cell homeostasis in both a quantitative and qualitative manner. Interleukin-7 (IL-7) is essential to T-cell homeostasis and several groups have shown reduced levels of the IL-7 receptor alpha-chain (CD127) on both CD4 and CD8 T-cells in viremic HIV+ patients. We have shown previously that ... More